Sign up to save your podcasts
Or
Share The Physician's Role in AI Procurement: Accountability Before Authority
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Physician's Role in AI Procurement: Accountability Before Authority
When an AI tool causes a patient harm, who gets called into the review meeting?
In almost every health system, the answer is the physician. The same physician who was brought into the procurement conversation as a validator after the vendor had already completed four executive demos, built the business case, and received board approval.
That is not a governance design. That is liability assignment after the fact. And it is one of the most expensive mistakes health systems are making in AI right now.
In this episode, Dr. Sarah Matt makes the case for what actual physician leadership in AI procurement looks like — and what the distinction is between being invited to validate a decision already made and having genuine authority over the clinical risk embedded in that decision.
The argument matters practically: health systems that build physician leadership into AI procurement at the authority level, not the validator level, move faster on AI implementation, not slower. Clinical buy-in is not a late-stage change management problem. It is an early-stage governance design decision.
Dr. Matt draws on her experience advising health systems and physician executives who have found themselves accountable for outcomes they did not control, in tools they did not select, for deployments they were brought into after the strategic architecture was already set.
This episode is for physician executives, CMOs, CMIOs, CNOs, and clinical leaders who are currently in, or about to enter, AI procurement conversations — and for the health system CEOs and boards who want to understand why physician leadership in AI keeps underperforming and what the structural fix requires.
What you will take away from this episode:
- The difference between physician validation and physician authority in AI procurement
- Why organizations that build genuine physician authority into AI governance move faster, not slower
- What the accountability gap looks like when something goes wrong, and how to close it before deployment
- The specific organizational design decisions that determine whether physician executives can succeed or are structurally set up to fail
—
Resources & Links:
📖 Get the Book: "The Borderless Healthcare Revolution" is available now on Amazon and major retailers.
💼 Work with Dr. Matt:
Looking for a keynote speaker or strategic advisor?
Visit: drsarahmatt.com
🔗 Connect on Social:
LinkedIn: https://www.linkedin.com/in/sarahmattmd/
YouTube: https://www.youtube.com/@DrSarahMatt-ClinicalRealist
📧 Subscribe to The Briefing: drsarahmatt.com/newsletter-signup
—
Disclaimer:
The views expressed on this podcast are those of Dr. Sarah Matt and her guests. They do not necessarily reflect the official policy or position of any affiliated institutions. This content is for informational and educational purposes only and does not constitute medical advice or a professional consulting relationship.
View all episodes
By Dr. Sarah MattWhen an AI tool causes a patient harm, who gets called into the review meeting?
In almost every health system, the answer is the physician. The same physician who was brought into the procurement conversation as a validator after the vendor had already completed four executive demos, built the business case, and received board approval.
That is not a governance design. That is liability assignment after the fact. And it is one of the most expensive mistakes health systems are making in AI right now.
In this episode, Dr. Sarah Matt makes the case for what actual physician leadership in AI procurement looks like — and what the distinction is between being invited to validate a decision already made and having genuine authority over the clinical risk embedded in that decision.
The argument matters practically: health systems that build physician leadership into AI procurement at the authority level, not the validator level, move faster on AI implementation, not slower. Clinical buy-in is not a late-stage change management problem. It is an early-stage governance design decision.
Dr. Matt draws on her experience advising health systems and physician executives who have found themselves accountable for outcomes they did not control, in tools they did not select, for deployments they were brought into after the strategic architecture was already set.
This episode is for physician executives, CMOs, CMIOs, CNOs, and clinical leaders who are currently in, or about to enter, AI procurement conversations — and for the health system CEOs and boards who want to understand why physician leadership in AI keeps underperforming and what the structural fix requires.
What you will take away from this episode:
- The difference between physician validation and physician authority in AI procurement
- Why organizations that build genuine physician authority into AI governance move faster, not slower
- What the accountability gap looks like when something goes wrong, and how to close it before deployment
- The specific organizational design decisions that determine whether physician executives can succeed or are structurally set up to fail
—
Resources & Links:
📖 Get the Book: "The Borderless Healthcare Revolution" is available now on Amazon and major retailers.
💼 Work with Dr. Matt:
Looking for a keynote speaker or strategic advisor?
Visit: drsarahmatt.com
🔗 Connect on Social:
LinkedIn: https://www.linkedin.com/in/sarahmattmd/
YouTube: https://www.youtube.com/@DrSarahMatt-ClinicalRealist
📧 Subscribe to The Briefing: drsarahmatt.com/newsletter-signup
—
Disclaimer:
The views expressed on this podcast are those of Dr. Sarah Matt and her guests. They do not necessarily reflect the official policy or position of any affiliated institutions. This content is for informational and educational purposes only and does not constitute medical advice or a professional consulting relationship.